|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-3-31
|
|
pubmed:abstractText |
Recent updates of the guidelines on the prevention of human immunodeficiency virus mother-to-child transmission have shortened the neonatal zidovudine prophylactic regimens from 6 to 4 weeks. We present a prospective observational study in a large cohort of mother-infant pairs and report that the 4-week regimen allows an earlier recovery of the anemia in these otherwise healthy infants.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1532-0987
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
376-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19949355-Adult,
pubmed-meshheading:19949355-Anemia,
pubmed-meshheading:19949355-Anti-HIV Agents,
pubmed-meshheading:19949355-Chemoprevention,
pubmed-meshheading:19949355-Drug Administration Schedule,
pubmed-meshheading:19949355-Female,
pubmed-meshheading:19949355-HIV Infections,
pubmed-meshheading:19949355-HIV-1,
pubmed-meshheading:19949355-Humans,
pubmed-meshheading:19949355-Infant, Newborn,
pubmed-meshheading:19949355-Infectious Disease Transmission, Vertical,
pubmed-meshheading:19949355-Pregnancy,
pubmed-meshheading:19949355-Pregnancy Complications, Infectious,
pubmed-meshheading:19949355-Reverse Transcriptase Inhibitors,
pubmed-meshheading:19949355-Zidovudine
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Antiretroviral-related hematologic short-term toxicity in healthy infants: implications of the new neonatal 4-week zidovudine regimen.
|
|
pubmed:affiliation |
Department of Pediatrics, Pediatric Infectious Diseases Unit, Hospital Sant Joan de Déu-Universitat de Barcelona, Barcelona, Spain.
|
|
pubmed:publicationType |
Journal Article
|
